Company news
Neon Bloom Inc. news in 2022
Neon Bloom Inc.'s news releases, calls and decks from 2022, newest first.
Bazelet™ to Supply Its Federally Legal Cannabis Genetics to DEA Approved Research Entities for Rigorous Scientific Research on the Clinical Effects of Cannabigerol (CBG)
June 7, 2022
Bazelet™ to Introduce its PECSA™ Ingredient at the National Restaurant Association Show May 21-24, 2022, Chicago, IL.
May 6, 2022
Bazelet Health Announces a U.S. Scientific Achievement and Scientific Proof of Cannabis America™, its 0% THC Tri-Purpose Cannabis Plant for Global Markets
April 28, 2022
International Senior Finance and Operations Executive named Chief Financial Officer and Chief Operating Officer of Neon Bloom’s wholly owned subsidiary Bazelet™
April 21, 2022
Bazelet Health announces PECSA™, its new federally legal, non-GMO plant-based cannabis ingredient for US and export markets
April 6, 2022
Bazelet Health announces PECSA™, its new federally legal, non-GMO plant-based cannabis ingredient for US and export markets.
April 5, 2022
Neon Bloom increases authorized Common Stock and creates Series B Preferred Stock
January 5, 2022